Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge
The licensed HPV vaccines are highly efficacious and induce high levels of neutralizing antibody levels, the assumed mediators of protection. However, a correlate of protection against HPV is lacking, and the evidence is still limited as to long-term persistence of antibodies, especially following r...
Saved in:
Main Authors: | J. Hoes (Author), H. Pasmans (Author), T. M. Schurink-van 't Klooster (Author), F. R. M. van der Klis (Author), R. Donken (Author), J. Berkhof (Author), H. E. de Melker (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ten years of HPV vaccination in the Netherlands: current evidence and future challenges in HPV-related disease prevention
by: V. Qendri, et al.
Published: (2018) -
Determinants of HPV-vaccination uptake and subgroups with a lower uptake in the Netherlands
by: A. C. de Munter, et al.
Published: (2021) -
Changes in (risk) behavior and HPV knowledge among Dutch girls eligible for HPV vaccination: an observational cohort study
by: Robine Donken, et al.
Published: (2018) -
The whole story: a systematic review of economic evaluations of HPV vaccination including non-cervical HPV-associated diseases
by: Anita W. M. Suijkerbuijk, et al.
Published: (2017) -
Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases
by: van der Klis F, et al.
Published: (2011)